Taming the reactive intermediates: the nazarov cyclization as a programmable platform

Medicinal Chemistry Research · Published 2026-07-31 · DOI 10.1007/s00044-026-03598-3

Authors (3)

Yunfei Cheng, Ye Yuan, Qun Sun

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Cheng, Y., Yuan, Y., Sun, Q. (2026). Taming the reactive intermediates: the nazarov cyclization as a programmable platform. Medicinal Chemistry Research. https://doi.org/10.1007/s00044-026-03598-3

Related articles

• Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies · Medicinal Chemistry Research · 2026 · Same journal
• Alisols A-C and their acetate derivatives: a review of natural occurrence, pharmacology, semisynthesis, pharmacokinetics, and metabolism · Medicinal Chemistry Research · 2026 · Same journal
• Investigation of reported small molecule P2Y6 receptor antagonists · Medicinal Chemistry Research · 2026 · Same journal
• Discovery of 3-(N-phenylsulfamoyl)-l-phenylalanine derivatives as novel and orally available LAT1-selective inhibitors · Medicinal Chemistry Research · 2026 · Same journal
• From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles · Medicinal Chemistry Research · 2026 · Same journal
• Inactivation of ornithine aminotransferase by (1R,4S)-4-Amino-3-(trifluoromethyl)cyclopent-2-ene-1-carboxylic acid via a stable quinonoid intermediate · Medicinal Chemistry Research · 2026 · Same journal
• Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights · Medicinal Chemistry Research · 2026 · Same journal
• Synthesis and antihepatoma activity of dimeric 1-O-acetylbritannilactone derivatives · Medicinal Chemistry Research · 2026 · Same journal
• Unrevealing the Role of Flavonoids in Mitigation of Non-Alcoholic Fatty Liver Disease · Medicinal Chemistry Research · 2026 · Same journal
• Development and evaluation of mitochondria-targeted caseinolytic protease (ClpP) agonist chemical probes in in vitro breast cancer models · Medicinal Chemistry Research · 2026 · Same journal